Women in England with incurable breast cancer to get life-extending drug on NHS

Automated summary
Covered by The Guardian – Health, BBC News – Health, STAT News. Thousands with HER2-low advanced breast cancer will have access to Enhertu after ministers strike deal on price Thousands of women in England with incurable breast cancer will get access to a life-extending drug on the…
Generated from the headlines and excerpts collected below — not written by the original publishers, and not a substitute for reading the source articles.
Trace this story
4 articles · 3 publishers
Veriqen did not detect explicit sourcing language in the available article text for this story.
Basic and Pro members see the full reporting-source breakdown, article-by-article evidence, and original-reporting details for every story.
How Veriqen traces this
Veriqen analyzes the article text available from publishers and looks for explicit sourcing language, such as references to reporting organizations, agencies, statements, and other identifiable sources. Articles that cite the same identified source can then be grouped together.
- Not all sourcing is written explicitly, so some real sourcing goes undetected.
- Publisher feeds may provide limited article text to analyze.
- Two articles citing the same source do not necessarily use the same report or come from the same origin.
- No detected sourcing does not mean an article has no sources.
- Veriqen traces attribution — it does not determine whether a claim is true or false.
Common assertions across coverage
4 articles · 3 publishers
Headline differences
- The Guardian – Health: Women in England with incurable breast cancer to get life-extending drug on NHS
- BBC News – Health: Cancer patient told she will get drug which could make her life longer
- STAT News: STAT+: England to cover AstraZeneca breast cancer drug, a result of U.K.-U.S. drug pricing deal
Upgrade to see headlines from every article in this story.
Basic and Pro members see the full coverage comparison, including every shared assertion, headline differences across all articles, and reporting-source context.
Comparisons are based on the article text available to Veriqen. Older or limited feeds may provide less text for comparison.
How Veriqen compares coverage
Veriqen looks for two kinds of explicit, structured assertions in the article text available to it: numbers tied to a recognized category (like a count of people injured, a dollar amount, or a percentage), and statements attributed to a named or role-based source. Similar assertions found across multiple articles in this story are grouped together and shown as one entry.
- “Appears in N articles” counts how many articles contain a similar assertion — it does not mean N sources independently confirmed it. Articles that cite the same reporting source (shown separately, where detected) are not independent of each other.
- Not all comparable assertions are written explicitly, so some go undetected.
- “Not detected in the available text” never means an article has no sources.
- Attribution to a source is not a claim that the underlying statement is true — only that it was attributed.
AI story briefAI-generated
Pro members get an AI-generated synthesis of this story's coverage — common assertions, differences, and source-overlap patterns Veriqen has already detected.
Timeline
- Women in England with incurable breast cancer to get life-extending drug on NHS
Thousands with HER2-low advanced breast cancer will have access to Enhertu after ministers strike deal on price Thousands of women in England with incurable breast cancer will get access to a life-extending drug on the…
- Cancer patient told she will get drug which could make her life longer
Patients in England with an incurable breast cancer can now access a life-extending drug on the NHS, two years after it was deemed too expensive by a health body.
- STAT+: England to cover AstraZeneca breast cancer drug, a result of U.K.-U.S. drug pricing deal
A breast cancer drug from AstraZeneca will now be available in England after a pricing deal was reached, in part a result of the U.S.-U.K. pharma pact.
- New hope for breast cancer patients as life-extending drug now on NHS in England
Compare coverage
How each outlet is reporting this story — headlines, timing, and details side by side. Veriqen doesn't rank or endorse any source; use this to compare framing yourself.
- Women in England with incurable breast cancer to get life-extending drug on NHS
Sep 17, 2026 at 5:00 AM
Thousands with HER2-low advanced breast cancer will have access to Enhertu after ministers strike deal on price Thousands of women in England with incurable breast cancer will get access to a life-extending drug on the…
- Cancer patient told she will get drug which could make her life longer
Sep 17, 2026 at 5:28 AM
Patients in England with an incurable breast cancer can now access a life-extending drug on the NHS, two years after it was deemed too expensive by a health body.
- New hope for breast cancer patients as life-extending drug now on NHS in England
Sep 17, 2026 at 1:32 PM
Enhertu, which can give patients an extra seven months to live on average, has been prescribed in Scotland for more than two years and is available.





